A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development

Journal of Immunology

Volumn 173, Issue 4, 2004, Pages 2280-2287

  Giarratana, Nadia ^a   Penna, Giuseppe ^a   Amuchastegui, Susana ^a   Mariani, Roberto ^a   Daniel, Kenn C ^a   Adorini, Luciano ^a  

^a BioXell SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXY 16,23 DIENE 26,27 HEXAFLUORO 19 NORVITAMIN D3; BXL 219; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LEUKOCYTE; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PANCREAS ISLET; PATHOGENESIS; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; TH1 CELL;

EID: 4043060025     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.4.2280     Document Type: Article

References (58)

1. Castano, L., and G. S. Eisenbarth. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 8:647.
2. Adorini, L., S. Gregori, and L. C. Harrison. 2002. Understanding autoimmune diabetes: insights from mouse models. Trends Mol. Med. 8:31.
3. Bach, J. F. 1994. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516.
4. Atkinson, M. A., and S. B. Wilson. 2002. Fatal attraction: chemokines and type 1 diabetes. J. Clin. Invest. 110:1611.
5. Grattan, M., Q. S. Mi, C. Meagher, and T. L. Delovitch. 2002. Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51:215.
6. Chen, M. C., F. Schuit, and D. L. Eizirik. 1999. Identification of IL-1β-induced messenger RNAs in rat pancreatic β cells by differential display of messenger RNA. Diabetologia 42:1199.
7. Frigerio, S., T. Junt, B. Lu, C. Gerard, U. Zumsteg, G. A. Hollander, and L. Piali. 2002. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 8:1414.
8. Bradley, L. M., V. C. Asensio, L. K. Schioetz, J. Harbertson, T. Krahl, G. Patstone, N. Woolf, I. L. Campbell, and N. Sarvetnick. 1999. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J. Immunol. 162:2511.
9. Kim, S. H., M. M. Cleary, H. S. Fox, D. Chantry, and N. Sarvetnick. 2002. CCR4-bearing T cells participate in autoimmune diabetes. J. Clin. Invest. 110:1675.
10. + T cells. J. Exp. Med. 197:643.
11. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461.
12. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217.
13. Akira, S. 2003. Mammalian Toll-like receptors. Curr. Opin. Immunol. 15:5.
14. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135.
15. Horwitz, M. S., and N. Sarvetnick. 1999. Viruses, host responses, and autoimmunity. Immunol. Rev. 169:241.
16. Zinkernagel, R. M. 2002. Antiinfection immunity and autoimmunity. Ann. NY Acad. Sci. 958:3.
17. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911.
18. Atkinson, M. A., and E. H. Leiter. 1999. The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5:601.
19. 3. Diabetologia 37:552.
20. 3, KH1060. Endocrinology 136:866.
21. 3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367.
22. Li, Q., and I. M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:725.
23. Hamaguchi, K., H. R. Gaskins, and E. H. Leiter. 1991. NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse. Diabetes 40:842.
24. Piemonti, L., B. E. Leone, R. Nano, A. Saccani, P. Monti, P. Maffi, G. Bianchi, A. Sica, G. Peri, R. Melzi, et al. 2002. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 51:55.
25. Prochazka, M., D. V. Serreze, W. N. Frankel, and E. H. Leiter. 1992. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41:98.
26. Atkinson, M. A., and G. S. Eisenbarth. 2001. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221.
27. Vives-Pi, M., N. Somoza, J. Fernandez-Alvarez, F. Vargas, P. Caro, A. Alba, R. Gomis, M. O. Labeta, and R. Pujol-Borrell. 2003. Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet β cells. Clin. Exp. Immunol. 133:208.
28. Wen, L., J. Peng, Z. Li, and F. S. Wong. 2004. The effect of innate immunity on autoimmune diabetes and the expression of toll-like receptors on pancreatic islets. J. Immunol. 172:3173.
29. 3. Crit. Rev. Eukaryotic Gene Expression 8:19.
30. Cardozo, A. K., H. Heimberg, Y. Heremans, R. Leeman, B. Kutlu, M. Kruhoffer, T. Orntoft, and D. L. Eizirik. 2001. A comprehensive analysis of cytokine-induced and nuclear factor-κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem. 276:48879.
31. 3. Proc. Natl. Acad. Sci. USA 92:10990.
32. 3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J. Biol. Chem. 278:49378.
33. 3: involvement of NF-κB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101:252.
34. 3 analogs as immunomodulatory agents. Trends Mol. Med. 8:174.
35. Adorini, L. 2002. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int. Immunopharmacol. 2:1017.
36. Griffin, M. D., N. Xing, and R. Kumar. 2003. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr. 23:117.
37. + regulatory T cells. J. Exp. Med. 194:847.
38. D'Ambrosio, D., F. Sinigaglia, and L. Adorini. 2003. Special attractions for suppressor T cells. Trends Immunol. 24:122.
39. Shimada, A., J. Morimoto, K. Kodama, R. Suzuki, Y. Oikawa, O. Funae, A. Kasuga, T. Saruta, and S. Narumi. 2001. Elevated serum IP-10 levels observed in type 1 diabetes. Diabetes Care 24:510.
40. Nicoletti, F., I. Conget, M. Di Mauro, R. Di Marco, M. C. Mazzarino, K. Bendtzen, A. Messina, and R. Gomis. 2002. Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type 1 diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107.
41. Xie, J. H., N. Nomura, M. Lu, S. L. Chen, G. E. Koch, Y. Weng, R. Rosa, J. Di Salvo, J. Mudgett, L. B. Peterson, L. S. Wicker, and J. A. DeMartino. 2003. Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J. Leukocyte Biol. 73:771.
42. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192:1515.
43. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732.
44. Jun, H., and J. Yoon. 2003. A new look at viruses in type 1 diabetes. Diabetes Metab. Res. Rev. 19:8.
45. von Herrath, M. G., M. Oldstone, D. Homann, and U. Christen. 2001. Is activation of autoreactive lymphocytes always detrimental? Viral infections and regulatory circuits in autoimmunity. Curr. Dir. Autoimmun. 4:91.
46. Ewel, C. H., D. O. Sobel, B. J. Zeligs, and J. A. Bellanti. 1992. Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 41:1016.
47. Sobel, D. O., D. Goyal, B. Ahvazi, J. W. Yoon, Y. H. Chung, A. Bagg, and D. M. Harlan. 1998. Low dose poly I:C prevents diabetes in the diabetes prone BB rat. J. Autoimmun. 11:343.
48. Serreze, D. V., K. Hamaguchi, and E. H. Leiter. 1989. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759.
49. Horwitz, M. S., A. Ilic, C. Fine, E. Rodriguez, and N. Sarvemick. 2002. Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest. 109:79.
50. Benoist, C., and D. Mathis. 2001. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2:797.
51. Aichele, P., M. F. Bachmann, H. Hengartner, and R. M. Zinkernagel. 1996. Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol. Rev. 152:21.
52. Christen, U., D. Benke, T. Wolfe, E. Rodrigo, A. Rhode, A. C. Hughes, M. B. Oldstone, and M. G. von Herrath. 2004. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Invest. 113:74.
53. Eriksson, U., R. Ricci, L. Hunziker, M. O. Kurrer, G. Y. Oudit, T. H. Watts, I. Sonderegger, K. Bachmaier, M. Kopf, and J. M. Penninger. 2003. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9:1484.
54. Moriyama, H., L. Wen, N. Abiru, E. Liu, L. Yu, D. Miao, R. Gianani, F. S. Wong, and G. S. Eisenbarth. 2002. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc. Natl. Acad. Sci. USA 99:5539.
55. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603.
56. Anders, H. J., V. Vielhauer, V. Eis, Y. Linde, M. Kretzler, G. Perez de Lema, F. Strutz, S. Bauer, M. Rutz, H. Wagner, H. J. Grone, and D. Schlondorff. 2004. Activation of Toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 18:534.
57. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283.
58. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286.